CTBP2, as an oncogene which can inhibit E-ca gene expression, is frequently reported to promote the cell proliferation, migration, invasion and drug resistance in a variety of cancers such as breast cancer [38], prostate cancer [39], esophageal cancer [40] and colorectal cancer [41]. The gene discussed is CTBP2; the disease is prostate cancer.